Metraipolis › archive › dc_0744368a4e45

Enhancing Herpes Zoster Vaccination Rates Among Oncology Outpatients: Impact of an In-House Vaccination Initiative — Europe PMC PMID:41228296

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41228296
DOI
10.3390/cancers17213502
License (as archived)
solo-consultazione
Archived
2026-11-08T22:46:29.563Z
SHA-256 of the archived text
6b20ff30fa09f3f61ef058b3f9b658accb0b7f3b5a0e97134de9d4ce367ebd45
Stable URL of this page
https://metraipolis.com/documento/dc_0744368a4e45

How to cite

Enhancing Herpes Zoster Vaccination Rates Among Oncology Outpatients: Impact of an In-House Vaccination Initiative — Europe PMC PMID:41228296 — Europe PMC (en), https://europepmc.org/article/MED/41228296 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0744368a4e45 (Metraipolis archive dc_0744368a4e45, sha256 6b20ff30fa09f3f61ef058b3f9b658accb0b7f3b5a0e97134de9d4ce367ebd45)
BibTeX
@misc{dc0744368a4e45,
  title = {Enhancing Herpes Zoster Vaccination Rates Among Oncology Outpatients: Impact of an In-House Vaccination Initiative — Europe PMC PMID:41228296},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41228296},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0744368a4e45; sha256 6b20ff30fa09f3f61ef058b3f9b658accb0b7f3b5a0e97134de9d4ce367ebd45},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41228296. Agents can read the archived copy with the MCP tool read_document.